Delix Therapeutics Expands Executive Leadership Team
Appoints Dr. Kurt Rasmussen, Former Eli Lilly Neuroscience Leader, NIH-NIDA Head of Therapeutics Division, as Chief Scientific Officer
Names Co-Founder Dr. David E. Olson as Chief Innovation Officer, Head of Scientific Advisory Board
BOSTON, July 6, ... Biopharmaceuticals, Neurology, Personnel Delix Therapeutics, psychoplastogens
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news